Skip to main content
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
SGLT2 Inhibitor
0
0.71
GLP-1 Receptor Agonist
0
0.68
Receptors
0
0.43
DPP-4 Inhibitors
0
0.36
Autoimmune Disease
0
0.21
Canada
0
0.07
Rheumatic Disease
0
0.07
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.46
Allergy & Clinical Immunology
0
0.23
Diabetes & Endocrinology
0
0.23
Internal Medicine
0
0.23
Edit Tags